Trends in cancer,
Journal Year:
2022,
Volume and Issue:
9(3), P. 198 - 211
Published: Dec. 31, 2022
Cytotoxic
T
lymphocytes
(CTLs)
are
antigen-specific
killer
cells
equipped
to
identify
and
eliminate
host
that
have
been
altered
through
infection
or
transformation.
Both
chimeric
antigen-receptor
(CAR)
cell
therapies
immune
checkpoint
blockade
(ICB)
based
on
successful
elimination
of
tumor
by
cytotoxic
effectors.
In
this
opinion
article,
we
outline
cell-intrinsic
mechanisms
which
defend
against
CTLs,
highlighting
pathways
confer
resistance
proposing
opportunities
for
combination
therapies.
We
discuss
how
exogenous
killing
entities
[e.g.,
supramolecular
attack
particles
(SMAPs)]
offer
a
novel
strategy
circumvent
cellular
mechanisms.
Our
article
highlights
the
importance
identifying,
quantifying,
targeting
defense
at
interface
between
CTLs
as
critical
consideration
in
development
immunotherapy
approaches.
Nature Immunology,
Journal Year:
2023,
Volume and Issue:
24(5), P. 869 - 883
Published: April 20, 2023
To
date,
no
immunotherapy
approaches
have
managed
to
fully
overcome
T-cell
exhaustion,
which
remains
a
mandatory
fate
for
chronically
activated
effector
cells
and
major
therapeutic
challenge.
Understanding
how
reprogram
CD8+
tumor-infiltrating
lymphocytes
away
from
exhausted
states
an
elusive
goal.
Our
work
provides
evidence
that
orthogonal
gene
engineering
of
T
secrete
interleukin
(IL)-2
variant
binding
the
IL-2Rβγ
receptor
alarmin
IL-33
reprogrammed
adoptively
transferred
acquire
novel,
synthetic
state,
deviated
canonical
exhaustion
displayed
superior
functions.
These
successfully
overcame
homeostatic
barriers
in
host
led-in
absence
lymphodepletion
or
exogenous
cytokine
support-to
high
levels
engraftment
tumor
regression.
unlocks
new
opportunity
rationally
endowed
with
ability
avoid
control
advanced
solid
tumors.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(9)
Published: Jan. 25, 2023
Abstract
T
cell
dysfunction‐induced
tumor
immune
escape
is
particularly
severe
in
glioblastoma
(GBM),
and
significantly
affects
the
efficacy
of
immunotherapy.
It
crucial
to
innovatively
reverse
dysfunction
for
improving
GBM
Herein,
remarkably
reversed
immunotherapy
boosted
by
repurposing
U.
S.
Food
Drug
Administration‐approved
antidepressant
paroxetine
(PX)
with
biomimetic
nanoparticles
(CS‐J@CM/6
NPs).
The
PX
successfully
applied
abrogate
sequestration
bone
marrow
GBM‐bearing
mice
increase
their
infiltration
tumor.
NPs
are
composed
ultrasmall
Cu
2−
x
Se
NPs,
JQ1,
membrane
modified
CD6,
efficiently
delivered
into
through
specific
interactions
between
CD6
activated
leukocyte
adhesion
molecule.
They
ameliorate
double
roles
loaded
which
simultaneously
decreases
expression
PD‐1
TIM‐3
on
cells,
PD‐L1
cells.
NP
also
induces
immunogenic
death
cells
activate
response.
synergistic
CS‐J@CM/6
notably
enhance
survival
mice.
This
work
provides
new
insights
“old
drugs”
advanced
NPs.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 22, 2024
Abstract
The
B
cell
response
in
the
germinal
centre
(GC)
reaction
requires
a
unique
bioenergetic
supply.
Although
mitochondria
are
remodelled
upon
antigen-mediated
receptor
stimulation,
mitochondrial
function
cells
is
still
poorly
understood.
To
gain
better
understanding
of
role
function,
here
we
generate
mice
with
cell-specific
deficiency
Tfam,
transcription
factor
necessary
for
biogenesis.
Tfam
conditional
knock-out
(KO)
display
blockage
GC
and
bias
differentiation
towards
memory
aged-related
cells,
hallmarks
an
aged
immune
response.
Unexpectedly,
blocked
KO
not
caused
by
defects
supply
but
associated
defect
remodelling
lysosomal
compartment
cells.
Our
results
may
thus
describe
lysosome
regulation
downstream
antigen
presentation
during
reaction,
dysruption
which
manifested
as
Journal of Proteome Research,
Journal Year:
2024,
Volume and Issue:
23(6), P. 1926 - 1936
Published: May 1, 2024
Data-independent
acquisition
has
seen
breakthroughs
that
enable
comprehensive
proteome
profiling
using
short
gradients.
As
the
coverage
continues
to
increase,
quality
of
data
generated
becomes
much
more
relevant.
Using
Spectronaut,
we
show
default
search
parameters
can
be
easily
optimized
minimize
occurrence
false
positives
across
different
samples.
an
immunological
infection
model
system
demonstrate
impact
adjusting
settings,
analyzed
Mus
musculus
macrophages
and
compared
their
spiked
withCandida
albicans.
This
experimental
enabled
identification
"false
positives"
as
Candida
albicans
peptides
proteins
should
not
present
in
musculus-only
We
reduced
positive"
identifications
by
89%
at
peptide
protein
level,
thereby
considerably
increasing
data.
also
these
incurred
a
moderate
cost,
only
reducing
overall
number
"true
each
biological
replicate
<6.7%
both
level.
believe
value
our
updated
extends
beyond
two-organism
analysis
would
great
any
DIA
experiment
analyzing
heterogeneous
populations
cell
types
or
tissues.
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 4, 2025
The
reduction
of
cellular
PD-L1
abundance
through
lysosomal
degradation
is
recognized
as
essential
for
effective
and
sustained
targeting
PD-L1-dependent
immune
evasion
in
cancer.
While
Hsc70
can
interact
with
to
promote
its
degradation,
the
overexpression
CMTM6
competitively
inhibits
this
interaction,
leading
blockade
degradation.
To
overcome
issue,
a
meso
chimeric
peptide
PEPPDL1
was
designed
specifically
bind
PD-1
binding
domain
instead
Hsc70/CMTM6
domain,
while
also
facilitate
dragging
into
Hsc70-mediated
chaperone-mediated
autophagy
(CMA),
thereby
achieving
In
order
enable
internalization
tumor
cells,
supramolecular
engineering
techniques
were
employed
terminal
modification
involving
sulfydryl
monovalent
gold
ion
(Au(I)),
both
facilitating
self-assembly
modified
nanospheres
termed
CTAC-PDL1
driven
by
aurophilic
interaction.
Furthermore,
based
on
bioinformatics
analysis
mRNA
expression
data
from
30
types
tumors
obtained
TCGA
database,
malignant
melanoma
identified
most
suitable
indication
due
specific
characteristics
immune.
As
expected,
effectively
reactivated
consequently
restored
anti-tumor
T
cell
immunity
B16F10-derived
mouse
model
maintaining
favorable
safety
profile.
Overall,
work
not
only
presents
an
alternative
approach
cancer
evasion,
but
provides
modularized
strategy
discovering
regulators
target
proteins
various
diseases.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: May 2, 2023
Abstract
Clinical
updates
suggest
conserving
metastatic
sentinel
lymph
nodes
(SLNs)
of
breast
cancer
(BC)
patients
during
surgery;
however,
the
immunoadjuvant
potential
this
strategy
is
unknown.
Here
we
leverage
an
immune-fueling
flex-patch
to
animate
SLNs
with
personalized
antitumor
immunity.
The
implanted
on
postoperative
wound
and
spatiotemporally
releases
immunotherapeutic
anti-PD-1
antibodies
(aPD-1)
adjuvants
(magnesium
iron-layered
double
hydroxide,
LDH)
into
SLN.
Genes
associated
citric
acid
cycle
oxidative
phosphorylation
are
enriched
in
activated
CD8
+
T
cells
(CTLs)
from
SLNs.
Delivered
aPD-1
LDH
confer
CTLs
upregulated
glycolytic
activity,
promoting
CTL
activation
cytotoxic
killing
via
metal
cation-mediated
shaping.
Ultimately,
patch-driven
could
long-termly
maintain
tumor
antigen-specific
memory,
protecting
against
high-incidence
BC
recurrence
female
mice.
This
study
indicates
a
clinical
value
SLN
therapy.
Molecular Biology and Evolution,
Journal Year:
2022,
Volume and Issue:
39(5)
Published: April 27, 2022
Mitochondria
are
essential
organelles
in
eukaryotic
cells
that
provide
critical
support
for
energetic
and
metabolic
homeostasis.
Although
the
elimination
of
pathogenic
mitochondrial
DNA
(mtDNA)
mutations
somatic
has
been
observed,
mechanisms
to
maintain
proper
functions
despite
their
mtDNA
mutation
load
poorly
understood.
In
this
study,
we
analyzed
more
than
30,000
single
human
peripheral
bone
marrow
mononuclear
cells.
We
observed
a
significant
overrepresentation
homoplasmic
B,
T,
natural
killer
(NK)
lymphocytes.
Intriguingly,
overall
mutational
burden
was
lower
hematopoietic
progenitors
myeloid
This
characteristic
landscape
indicates
genetic
bottleneck
during
lymphoid
development,
as
confirmed
with
single-cell
datasets
from
multiple
platforms
individuals.
further
demonstrated
replication
lags
behind
cell
proliferation
both
pro-B
pre-B
progenitor
cells,
thus
likely
causing
by
diluting
copies
per
cell.
Through
computational
simulations
approximate
Bayesian
computation
(ABC),
recapitulated
lymphocyte-specific
estimated
minimal
<30
NK
lineages.
Our
integrative
analysis
revealed
novel
process
lymphoid-specific
bottleneck,
illuminating
potential
mechanism
used
highly
metabolically
active
immune
limit
load.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: April 25, 2023
CD8
+
T
cells,
a
cytotoxic
lymphocyte,
are
key
component
of
the
tumor
immune
system,
but
they
enter
hyporeactive
cell
state
in
long-term
chronic
inflammation,
and
how
to
rescue
this
depleted
is
direction
research.
Current
studies
on
exhaustion
have
found
that
mechanisms
responsible
for
their
heterogeneity
differential
kinetics
may
be
closely
related
transcription
factors
epigenetic
regulation,
which
serve
as
biomarkers
potential
immunotherapeutic
targets
guide
treatment.
Although
importance
immunotherapy
cannot
overstated,
pointed
out
gastric
cancer
tissues
better
anti-tumor
composition
compared
other
tissues,
indicate
gastrointestinal
cancers
more
promising
prospects
development
precision-targeted
immunotherapy.
Therefore,
present
study
will
focus
involved
exhaustion,
then
review
landscapes
well
clinical
applications,
provide
clear
vision
future
immunotherapies.